iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN
JJS was delisted on the 7th of June, 2023.
5 hedge funds and large institutions have $7.2M invested in iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
5% less capital invested
Capital invested by funds: $7.55M → $7.2M (-$356K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$303K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$483K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$589 |
JJS Hedge Fund Activity: Q4 2022 in Review
5 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN (JJS) for Q4 2022, worth a combined $7.2M — down 4.7% from $7.55M a quarter earlier.
Fund positioning in JJS was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Jane Street, adding an estimated $303K. The largest seller was Flow Traders U.S., cutting an estimated $483K.
- 5 institutional investors held iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN (JJS) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $7.2M of iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN stock for Q4 2022, down 4.7% quarter-over-quarter.
- 0 funds opened new iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN positions in Q4 2022 and 0 closed out.
- The largest iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN buyer in Q4 2022 was Jane Street, an estimated $303K added.
- The largest iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN seller in Q4 2022 was Flow Traders U.S., an estimated $483K sold.
Based on aggregated 13F filings for Q4 2022.